CogState Aktsia

CogState EBITDA

Delisted·15. juuni 2026

EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) ettevõttest CogState (CGS.AX) seisuga 11. aug 2026 on 15,71 M USD. Eelmisel aastal oli EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) 9,51 M USD — muutus 65,19% (kõrgem).

EBITDA

15,71 MUSD

YoY

65,19%

Viimati uuendatud:

EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) ettevõttest CogState on 2026 15,71 M USD. EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) ettevõttest CogState oli 2025 9,51 M USD. See väheneb 65,19% kõrgem võrreldes eelmise aastaga.
Access this data via the Eulerpool API

CogState Aktsiate analüüs

Mida CogState teeb? CogState Ltd is an Australian company specializing in the development of innovative cognitive tests. The company was founded in 1999 and is based in Melbourne, Australia. It conducts computer-based cognitive tests to gather information about the cognitive functioning of patients and athletes. The CogState tests are specifically designed to measure cognitive abilities in areas such as perception, reaction time, memory, and attention. The business model of CogState is based on the development, marketing, and sale of cognitive test products. The company generates a significant portion of its revenue through licensing its tests to pharmaceutical and biotech companies that want to test their medications or therapies more effectively. CogState also has a strong presence in the sports industry, offering its tests to sports teams and individual athletes. CogState was founded in 1999 by Paul Maruff, a neuropsychologist, who was searching for better and more effective ways to conduct cognitive tests. Initially, the tests developed by CogState were exclusively for medical research, but it was quickly discovered that they could be useful in other areas as well. In 2004, Richard Kimber joined the company as CEO and Chairman, bringing his experience from the biotechnology industry. CogState offers a variety of cognitive tests for various applications, including clinical trials, sports performance analysis, and brain injury treatment. The tests are licensed by different companies and organizations that use them to test the effects of medications and therapies on cognitive functions or to assess performance and injuries in sports. One example of a CogState product is the AX Continuous Tracker Test. This test was developed for clinical use and allows for continuous and accurate measurement of cognitive functions in patients with psychiatric and neurological disorders. Another application is the SPARQ test for athletes, which allows for the measurement and improvement of athletes' cognitive abilities. In summary, CogState Ltd is a leading company in the field of cognitive tests. The company specializes in developing innovative cognitive tests for the specific requirements of pharmaceutical and biotech companies, as well as sports organizations. The tests are used worldwide by various organizations and have a significant impact on the treatment of psychiatric and neurological disorders, as well as performance and injury analysis in sports. CogState on üks populaarsemaid ettevõtteid Eulpoolist.

Sageli esitatud küsimused CogState aktsia kohta

CogState EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) on 2026. aastal 15,71 M USD.

EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) ettevõttest CogState muutus 9,51 M USD-st 15,71 M USD-ks, mis vastab 65,19% muutusele. Väärtus on kõrgem kui eelmisel aastal.

Eulpoolist leiate EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) CogState täieliku ajaloolise arengu alates 2006. aastast – koos aastate väärtustega, graafikutega ja üksikasjalike analüüsidega.

EBITDA mõõdab operatiivset sooritust enne finantsstruktuuri, maksustamiskeskkonna ja mitterahalist amortisatsioonimaksude mõju.

EBITDA = EBIT + amortisatsioon ja amortisatsioon

EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) USD on investorite jaoks määrav tegur. Selle näitaja muutused võivad signaliseerida põhialuste paranemist või halvenemist, mõjutades otseselt aktsia hinda. Eulpoolis saate EBITDA (kasum enne intresse, makse, amortisatsiooni ja amortisatsiooni) CogState ajaloolist arengut ja reaalajas andmeid jälgida.

Access this data via the Eulerpool API

Kasumi- ja kahjumiaruanne — CogState

Kõik finantsnäitajad — CogState